Sort
23,748 grants matching “melanoma”
Renalase inhibition for treatment of unresectable melanoma
$481,894Harriet M Kluger · Yale University · R01 · FY2020 · CA
Project 1: Targeted therapeutics for pediatric low-grade glioma
$481,888Benjamin Harris Kann · Brigham And Women'S Hospital · P50 · FY2025 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$481,846Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Cell Phone Based Polarized Light Imaging
$481,830Gerard L Cote · Texas A&M Engineering Experiment Station · · FY2014 · ENG
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$481,738Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$481,728Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Targeting PPT1 in the Tumor Microenvironment
$481,705Ravi K Amaravadi · Wistar Institute · P01 · FY2023 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$481,659Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Topical Retinoids for Chemoprevention of Melanoma
$481,630Ivrea, Inc. · R44 · FY2003 · CA
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
$481,629Harvard University (Medical School) · R01 · FY2001 · CA
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
$481,506Michael A Teitell · University Of California Los Angeles · R01 · FY2014 · CA
Renalase inhibition for treatment of unresectable melanoma
$481,477Harriet M Kluger · Yale University · R01 · FY2021 · CA
Targeting HSP70 for Melanoma Therapy
$481,458Maureen E Murphy · Wistar Institute · P01 · FY2019 · CA
The filopodial tip complex in adhesion, migration, and signaling
$481,391Richard E Cheney · Univ Of North Carolina Chapel Hill · R01 · FY2019 · GM
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$481,349Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$481,288Iman Osman · New York University School Of Medicine · R01 · FY2018 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$481,271Zhong-Yin Zhang · Purdue University · R01 · FY2017 · CA
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
$481,065Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$481,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2018 · OD
Targeting PPT1 in the Tumor Microenvironment
$480,986Ravi K Amaravadi · Wistar Institute · P01 · FY2022 · CA
Defining critical aspects of environmental ultraviolet exposure in melanogenesis
$480,980Myles G Cockburn · University Of Southern California · R01 · FY2009 · ES
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$480,895Periasamy Selvaraj · Emory University · R01 · FY2020 · CA
Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver
$480,878Michelle Hughes · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$480,848David Joseph Weber · University Of Maryland Baltimore · R01 · FY2011 · CA
Breaking down the matrix in the melanoma microenvironment: Mechanism and therapeutic evaluation
$480,750Yuhang Zhang · University Of Cincinnati · R15 · FY2018 · CA